Pentasa

DRUG2 trials

Sponsors

Ferring Pharmaceuticals

Conditions

Crohn´s DiseaseUlcerative Colitis

Phase 3

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

CompletedNCT00209300

Ferring PharmaceuticalsUlcerative Colitis

Start: 2005-05-31End: 2007-06-30Updated: 2011-05-19

A Study With Pentasa in Patients With Active Crohn's Disease

TerminatedNCT00862121

Ferring PharmaceuticalsCrohn´s Disease

Start: 2009-04-30End: 2010-10-31Updated: 2012-03-16